ArticlePloS one2025

Risk of cardiovascular disease and death in patients with breast cancer receiving anthracycline-based therapy: A retrospective cohort study.

Yu-Cheol Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.